Leading Research into Head & Neck Cancer

A new era for thyroid cancer

Dr Malin Pedersen and Eva Crespo Rodriguez

Tag: New treatment

<strong>Tag:</strong> New treatment

Under the guidance of Dr Malin Pedersen, Scientific Officer Eva Crespo Rodriguez is testing new drugs which can awaken the patient’s immune system to fight thyroid cancer.

Like all other cancers, thyroid cancer is a disease that affects the DNA, or genetic code of cells.  These genetic changes in cancer can allow tumours to grow more efficiently, spread and become resistant to treatment.

In this project, Dr Pedersen and Eva are testing new drug combinations for patients with treatment-resistant thyroid cancer who do not respond to conventional therapies.

One of the new approaches being tested will involve using drugs that can awaken the patient’s own immune system to the presence of the tumour.  These so-called immunotherapies are showing huge promise across a wide variety of tumour types and Dr Pedersen has already shown this approach can be effective for melanoma but as yet no-one has tested their efficacy in thyroid tumours.

Dr Pedersen says: “I have had significant success with a similar project for malignant melanoma and now with the support of the Oracle Cancer Trust, I am confident that I can make important discoveries that will benefit patients with thyroid cancers.”

Without the research grant from Oracle, which has been supporting the initial exploratory work for this important project, Dr Pedersen would not be able to compete for the funding to take her treatments into a larger clinical trial.

It is hoped that this work will lay the groundwork for the development of new therapies which can confer durable, complete remission of the disease in patients.

New-era-thyroid-cancer

Help fund this project

For more information on funding this project specifically please email us

Donate now and together we can save more lives by beating cancer sooner.

Dr Malin Pedersen
Dr Malin Pedersen

Project type:                       Project

Project Leader:
Dr Malin Pedersen

Researcher:
Eva Crespo

Commencement date:   February 2017

Length of project:                    2 years

Funding provided:
£123,773

Funder:
The Swire Charitable Trust, The Adrian Swire Charitable Trust and the late David Peake

Location:                               The Institute of Cancer Research

Follow us

Get in touch

Call 020 3875 8991

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.